We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-0.29%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.22B
AUM Growth
+$53.1M
Cap. Flow
+$124M
Cap. Flow %
2.37%
Top 10 Hldgs %
65.84%
Holding
128
New
6
Increased
35
Reduced
25
Closed
11

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$21.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$15.6M
3
BABA icon
Alibaba
BABA
+$14.5M
4
META icon
Meta Platforms (Facebook)
META
+$11.7M
5
BIDU icon
Baidu
BIDU
+$11.7M

Sector Composition

Rank Sector Weight
1 Financials 26.04%
2 Healthcare 25.69%
3 Communication Services 13.78%
4 Consumer Discretionary 12.54%
5 Consumer Staples 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBN icon
26
ICICI Bank
IBN
$108B
$23.5M 0.45%
3,594,405
+617,761
+21% +$3.98M
CNC icon
27
Centene
CNC
$30.9B
$19.9M 0.38%
557,120
-112,200
-17% -$3.52M
SHPG
28
DELISTED
Shire pic
SHPG
$19.6M 0.38%
106,494
+1,570
+1% +$283K
BIIB icon
29
Biogen
BIIB
$30.7B
$18.7M 0.36%
77,147
-6,500
-8% -$1.71M
CI icon
30
Cigna
CI
$78.7B
$13.5M 0.26%
105,300
-10,450
-9% -$1.38M
TEVA icon
31
Teva Pharmaceuticals
TEVA
$40.8B
$13.3M 0.25%
265,000
-53,000
-17% -$2.82M
ESRX
32
DELISTED
Express Scripts Holding Company
ESRX
$12.8M 0.24%
168,301
-13,900
-8% -$1.02M
JAZZ icon
33
Jazz Pharmaceuticals
JAZZ
$16.2B
$12.2M 0.23%
86,189
-8,500
-9% -$1.25M
CEMP
34
DELISTED
Cempra, Inc.
CEMP
$12M 0.23%
730,630
-34,300
-4% -$605K
MRK icon
35
Merck
MRK
$323B
$11.8M 0.23%
214,208
HCA icon
36
HCA Healthcare
HCA
$91.2B
$11.2M 0.21%
145,075
NKE icon
37
Nike
NKE
$64.7B
$11.1M 0.21%
201,880
+16,900
+9% +$963K
HZNP
38
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$11M 0.21%
665,000
+3,500
+0.5% +$56.6K
TMO icon
39
Thermo Fisher Scientific
TMO
$214B
$10.9M 0.21%
73,640
+69,000
+1,487% +$10.2M
TSM icon
40
TSMC
TSM
$2.01T
$8.4M 0.16%
320,260
-22,600
-7% -$564K
BMRN icon
41
BioMarin Pharmaceuticals
BMRN
$11.9B
$8.37M 0.16%
107,575
DVA icon
42
DaVita
DVA
$15.5B
$7.4M 0.14%
95,691
COO icon
43
Cooper Companies
COO
$14.2B
$7.36M 0.14%
171,600
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.2M 0.14%
185,500
+60,000
+48% +$2.16M
ABBV icon
45
AbbVie
ABBV
$470B
$6.66M 0.13%
107,500
COR icon
46
Cencora
COR
$62.2B
$5.16M 0.1%
65,100
RLYP
47
DELISTED
RELYPSA INC COM
RLYP
$4.96M 0.09%
268,000
ALXN
48
DELISTED
Alexion Pharmaceuticals
ALXN
$4.9M 0.09%
41,961
+400
+1% +$56.8K
MDVN
49
DELISTED
MEDIVATION, INC.
MDVN
$4.44M 0.09%
73,622
-16,000
-18% -$907K
EGRX
50
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.78M 0.07%
97,407
-101,500
-51% -$4.23M

Similar funds

C WorldWide Group's Q2 2016 Portfolio in Review

As of Q2 2016, C WorldWide Group held 128 positions worth $5.22B, up 1% from $5.17B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

C WorldWide Group's Q2 2016 filing shows 6 new, 35 increased, 25 reduced and 11 closed positions. Its largest new stake was Adeptus Health Inc: 50,000 shares worth $2.58M. The largest sale was Air Methods Corp, an estimated $5.53M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Communication Services.

  • C WorldWide Group's largest Q2 2016 buy was Adeptus Health Inc: 50,000 shares worth $2.58M.
  • C WorldWide Group added most to Visa in Q2 2016, an estimated $21.7M increase.
  • C WorldWide Group's biggest Q2 2016 reduction was Air Methods Corp, cutting an estimated $5.53M.
  • C WorldWide Group fully exited Tetraphase Pharmaceuticals, Inc. in Q2 2016, selling an estimated $2.14M.
  • C WorldWide Group's ten largest holdings make up 66% of its $5.22B portfolio in Q2 2016.
  • C WorldWide Group opened 6 new positions and closed 11 in Q2 2016.
  • C WorldWide Group's portfolio value rose 1% quarter-over-quarter to $5.22B.

Based on C WorldWide Group's 13F filing for Q2 2016, filed 29 Jul 2016.